exist
renin
angiotensin
system
ra
major
physiolog
regul
known
sinc
tigerstedt
bergman
first
discov
enzym
renin
centuri
ago
nearli
year
initi
discoveri
renin
irvin
page
unit
state
braun
menendez
argentina
independ
discov
pressor
hormon
angiotonin
hypertensin
later
agreeabl
call
angiotensin
ang
know
hormon
octapeptid
pressor
hormon
ang
ii
produc
sequenti
cleavag
protein
aogen
ang
renin
ang
ang
ii
angiotensinconvert
enzym
ace
linear
hydrolysi
cascad
undisput
mani
year
studi
laboratori
show
previous
consid
inert
metabolit
ang
ii
ang
caus
releas
vasopressin
rat
brain
hypothalamu
studi
first
demonstr
biolog
activ
peptid
within
ra
ang
iimedi
discoveri
ang
expand
knowledg
complex
ra
garner
increas
support
potenti
target
therapeut
treatment
diseas
hypertens
heart
diseas
even
cancer
chapter
focus
function
role
ang
heart
well
import
contribut
angiotensinconvert
enzym
play
degrad
ang
ii
ang
evid
protect
role
counterbalanc
arm
ra
continu
accumul
also
comment
identif
new
angiotensin
peptid
upstream
ang
call
angiotensin
may
function
tissu
altern
precursor
angiotensin
peptid
product
diagram
current
view
renin
angiotensin
system
shown
fig
presenc
ang
heart
abil
heart
produc
ang
known
time
ang
identifi
cardiomyocyt
heart
cardiac
fibroblast
averil
et
al
show
express
augment
coronari
arteri
ligat
sever
studi
shown
ang
synthes
heart
show
direct
convers
ang
ii
ang
isol
heart
normal
hypertens
rat
earli
studi
investig
direct
role
ang
action
heart
show
protect
ischemiainduc
cardiac
dysfunct
may
due
part
activ
sodium
pump
addit
studi
cardiomyopathi
hamster
show
antiarrhythm
effect
ang
mediat
hyperpolar
heart
cell
evid
ang
direct
posit
effector
heart
stem
data
show
antifibrot
antihypertroph
action
ang
peptid
thu
short
halflif
sever
studi
investig
stabl
analog
ang
call
administr
ang
analog
associ
improv
cardiac
function
diabet
rat
improv
baroreceptor
sensit
potenti
vasodil
action
bradykinin
ma
receptor
mediat
signal
mechan
produc
ang
show
transfect
cultur
myocyt
antisens
oligonucleotid
ma
receptor
block
ang
mediat
inhibit
serumstimul
mitogenactiv
protein
kinas
mapk
activ
wherea
sens
oligonucleotid
ineffect
keep
find
chronic
ma
defici
lead
impair
handl
cardiomyocyt
cultur
clear
relationship
salt
intak
preval
hypertens
shown
abund
epidemiolog
intervent
studi
give
support
current
recommend
sodium
intak
mg
per
day
american
heart
associ
hand
despit
numer
studi
suggest
interrupt
ma
receptor
axi
may
lead
hypertens
cardiac
dysfunct
littl
known
respons
alter
sodium
intak
respect
blood
pressur
chang
target
organ
damag
laboratori
among
first
one
report
import
tonic
depressor
activ
ang
mainten
blood
pressur
spontan
hypertens
rat
endogen
ra
activ
induc
chronic
salt
deplet
furthermor
face
unchang
plasma
ang
enhanc
vascular
sensit
endogen
ang
saltrestrict
state
suggest
signific
amplif
ang
interact
subsequ
studi
also
reveal
condit
increas
renal
ang
ii
due
salt
deplet
goldblatt
hypertens
endogen
ang
counterbalanc
effect
ang
ii
maintain
glomerular
filtrat
rate
renal
plasma
flow
thu
could
possibl
insuffici
synthesi
activ
ma
may
critic
import
mechan
saltsensit
hypertens
inde
shown
femal
dahl
saltsensit
rat
fed
highsalt
diet
chronic
ang
supplement
reduc
increas
blood
pressur
improv
aortic
renal
blood
flow
increas
prostacyclin
releas
believ
increas
plasma
level
nitric
oxid
follow
ang
infus
respons
observ
vasodilatori
effect
also
shown
acut
vasodil
ang
augment
rat
fed
highsodium
versu
lowsalt
diet
due
increas
vasodilatori
decreas
vasoconstrictor
prostanoid
antagonist
nitric
oxideindepend
effect
ang
ang
iiinduc
vasoconstrict
aortic
ring
rat
fed
highsodium
diet
abolish
rat
fed
lowsodium
diet
thu
studi
warrant
defin
precis
finetun
mechan
ang
regul
blood
pressur
flow
well
vascular
reactiv
differ
statu
sodium
intak
context
import
note
saltsensit
hypertens
patient
omapatrilat
dual
ace
neprilysin
inhibitor
effect
reduc
blood
pressur
increas
urinari
excret
ang
studi
clearli
point
besid
inhibit
ang
ii
product
degrad
atrial
natriuret
peptid
bradykinin
ang
renal
origin
may
contribut
hypotens
effect
omapatrilat
patient
whose
blood
pressur
sensit
sodium
intak
final
mind
antihypertroph
antifibrot
effect
ang
intrigu
hypothes
saltinduc
left
ventricular
remodel
renal
injuri
observ
differ
form
experiment
human
hypertens
may
least
part
govern
alter
ma
axi
fact
dahl
saltsensit
rat
fed
highsalt
diet
cardiac
enlarg
fibrosi
associ
increas
cardiac
angiotensinogen
reduc
cardiac
mrna
treatment
receptor
antagonist
mineralocorticoid
receptor
blocker
revers
effect
salt
gene
express
importantli
therapi
amelior
saltinduc
cardiac
remodel
along
reduct
angiotensinogen
ace
mrna
therefor
seem
effect
saltintak
variat
ra
blockad
may
ultim
depend
net
effect
two
oppos
arm
ra
furthermor
low
sodium
intak
wistar
rat
reduc
renal
ace
mrna
activ
effect
amplifi
ace
inhibit
neither
plasma
ang
ii
ang
affect
low
sodium
intak
ace
inhibit
increas
plasma
ang
shift
balanc
two
oppos
peptid
toward
ang
effect
low
sodium
intak
moreov
blood
pressur
lowest
group
treat
ace
inhibitor
lowsalt
intak
find
studi
corrobor
well
previou
conclus
antihypertens
cardioren
protect
effect
ra
blockad
stem
least
part
ang
pathway
activ
effect
may
pronounc
follow
dietari
sodium
restrict
studi
clearli
necessari
explor
whether
benefici
effect
dietari
sodium
alter
andor
pharmacolog
intervent
inde
depend
prefer
ultim
ang
iiang
balanc
target
organ
discoveri
biolog
effector
peptid
ang
repres
first
expans
classic
ra
cascad
known
peptid
member
ra
elicit
physiolog
function
howev
format
ang
remain
elus
sever
year
welch
colleagu
first
show
ang
could
form
tradit
ra
precursor
peptid
ang
endopeptidas
includ
prolyl
oligopeptidas
pop
ec
neprilysin
nep
ec
thimet
oligopeptidas
top
ec
known
prolyl
oligopeptidas
could
cleav
bond
ang
ii
studi
support
convinc
vivo
evid
moreov
studi
yang
et
al
found
prolyl
carboxypeptidas
pcp
ec
lysosom
enzym
acid
ph
optimum
could
cleav
ang
ii
ang
hydrolysi
appear
intracellular
cleavag
observ
acid
ph
optimum
pcp
provid
doubt
physiolog
role
enzym
produc
ang
two
independ
research
group
describ
homolog
ace
call
angiotensinconvert
enzym
viabl
ang
form
enzym
ang
ii
discov
shortli
discoveri
vicker
et
al
show
could
cleav
ang
ii
ang
high
affin
also
cleav
apelin
opioid
peptid
dynorphin
similar
affin
involv
modul
peptid
vivo
remain
clarifi
subsequ
studi
reveal
gener
ang
human
fail
heart
tissu
depend
ang
ii
suggest
requir
cleavag
ang
ii
ang
studi
laboratori
repres
first
direct
vivo
evid
particip
hydrolyz
ang
ii
ang
heart
isol
normal
hypertens
rat
show
hypertrophi
heart
hypertens
rat
almost
complet
reliant
product
ang
ang
ii
wherea
normal
heart
less
import
wide
express
mani
tissu
human
rodent
includ
heart
addit
work
laboratori
first
demonstr
cardiac
express
mrna
regul
action
ang
ii
via
receptor
pathway
recent
studi
show
neg
action
ang
ii
cardiac
mrna
could
mimick
addit
effect
could
block
inhibitor
mitogenactiv
protein
map
kinas
kinas
suggest
ang
ii
activ
reduc
import
regul
cardiac
function
determin
crackow
colleagu
demonstr
genet
inactiv
mice
result
sever
bloodpressureindepend
systol
impair
cardiac
function
associ
signific
accumul
circul
cardiac
ang
ii
concomit
genet
inactiv
ace
complet
rescu
cardiac
phenotyp
implic
elev
ang
ii
cardiac
dysfunct
observ
mice
studi
first
support
vivo
import
regul
cardiac
function
ang
ii
metabol
addit
find
two
addit
mice
strain
gener
separ
group
one
strain
exhibit
cardiac
dysfunct
respons
pressur
overload
also
associ
increas
cardiac
ang
ii
impair
cardiac
dysfunct
abrog
coadministr
receptor
antagonist
candesartan
contrast
gurley
et
al
report
genet
inactiv
mix
mous
background
induc
function
impair
heart
suggest
import
cardiac
may
depend
genet
background
anim
model
context
mercur
et
al
report
eightfold
increas
ang
heart
transgen
anim
associ
less
ventricular
hypertrophi
fibrosi
nontransgen
litterm
respons
hypertens
challeng
view
opposit
approach
determin
physiolog
import
favor
cardioprotect
role
enzym
inde
overexpress
protect
heart
ang
iiinduc
cardiac
hypertrophi
myocardi
fibrosi
rat
moreov
elev
cardiac
exhibit
partial
rescu
cardiac
function
deficit
induc
coronari
arteri
ligat
rat
cardioprotect
persona
given
illustr
regul
patholog
condit
three
import
independ
studi
show
cardiac
upregul
human
rodent
model
heart
failur
moreov
first
show
secret
elev
cardiac
effluent
hypertrophi
heart
suggest
enzym
attempt
protect
heart
progress
toward
overt
failur
known
transgen
rat
data
recent
support
human
studi
measur
activ
human
plasma
author
show
inde
markedli
increas
patient
diagnos
heart
failur
intriguingli
lambert
et
al
recent
demonstr
tumor
necrosi
factor
convertas
particip
shed
membran
studi
report
upregul
heart
failur
collect
data
physiolog
import
cardiac
clear
exert
cardioprotect
role
earli
stage
cardiac
hypertrophi
overt
heart
failur
although
effort
may
insuffici
overcom
progress
heart
diseas
howev
studi
requir
determin
import
discoveri
endogen
inhibitor
well
emerg
data
function
receptor
sar
coronaviru
may
provid
altern
therapeut
target
treatment
cardiovascular
diseas
year
question
rais
regard
capabl
cardiac
vascular
tissu
synthes
ang
ii
heart
remain
critic
exampl
although
larg
bodi
evid
suggest
exist
local
tissu
ra
regul
cardiac
function
remodel
studi
reveal
low
level
gene
express
cardiac
renin
aogen
neither
identif
renin
cardiac
mast
cell
exclud
uptak
mechan
blood
compart
find
renin
activ
bind
prorenin
proreninrenin
receptor
constru
evid
local
product
cellular
renin
likewis
aogen
gene
express
cardiac
tissu
report
low
express
level
question
much
aogen
mrna
due
presenc
endotheli
cell
intracoronari
vessel
cardiac
fibroblast
answer
current
view
ra
complex
system
entail
sever
level
regul
process
expand
identif
angiotensin
ang
upstream
propeptid
ang
investig
first
isol
novel
aogenderiv
peptid
rat
small
intestin
consist
amino
acid
peptid
term
base
possibl
role
ang
ii
precursor
ang
constrict
aortic
strip
infus
intraven
rais
blood
pressur
rat
vasoconstrictor
respons
ang
abolish
either
captopril
blocker
current
studi
laboratori
demonstr
exist
ang
heart
kidney
spontan
hypertens
rat
shr
primarili
restrict
cardiac
myocyt
renal
tubular
cell
addit
cardiac
content
ang
significantli
augment
heart
shr
compar
wistarkyoto
wki
control
moreov
insight
process
ang
ang
ang
ii
ang
accomplish
studi
effect
exogen
administ
ang
isol
heart
normotens
hypertens
rat
strain
studi
show
process
ang
ang
ang
ii
ang
moreov
group
wki
shr
investig
studi
addit
specif
renin
inhibitor
prepar
manner
alter
product
angiotensin
ang
data
show
ang
process
activ
angiotensin
peptid
nonrenin
mechan
work
requir
ascertain
biolog
role
ang
data
expand
knowledg
mechan
ra
regul
express
angiotensin
tissu
discoveri
counterbalanc
ma
arm
ra
expand
knowledg
intrins
mechan
system
regul
homeostasi
tissu
perfus
physiolog
patholog
rapid
advanc
field
suggest
altern
approach
suppress
patholog
action
ang
ii
enhanc
counterregulatori
action
ang
augment
activ
moreov
discoveri
ang
multipl
tissu
includ
heart
may
provid
addit
mechanist
insight
could
lead
better
treatment
manag
hypertens
heart
failur
